143 related articles for article (PubMed ID: 20936705)
21. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
Reed TT; Pierce WM; Markesbery WR; Butterfield DA
Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
[TBL] [Abstract][Full Text] [Related]
22. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
[TBL] [Abstract][Full Text] [Related]
23. Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.
Hänggi J; Streffer J; Jäncke L; Hock C
J Alzheimers Dis; 2011; 26(4):719-34. PubMed ID: 21709375
[TBL] [Abstract][Full Text] [Related]
24. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
25. Proteomics analysis of the Alzheimer's disease hippocampal proteome.
Sultana R; Boyd-Kimball D; Cai J; Pierce WM; Klein JB; Merchant M; Butterfield DA
J Alzheimers Dis; 2007 May; 11(2):153-64. PubMed ID: 17522440
[TBL] [Abstract][Full Text] [Related]
26. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease.
Peng S; Wuu J; Mufson EJ; Fahnestock M
J Neuropathol Exp Neurol; 2004 Jun; 63(6):641-9. PubMed ID: 15217092
[TBL] [Abstract][Full Text] [Related]
27. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
Reed T; Perluigi M; Sultana R; Pierce WM; Klein JB; Turner DM; Coccia R; Markesbery WR; Butterfield DA
Neurobiol Dis; 2008 Apr; 30(1):107-20. PubMed ID: 18325775
[TBL] [Abstract][Full Text] [Related]
28. Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease.
Wang S; Yang F; Petyuk VA; Shukla AK; Monroe ME; Gritsenko MA; Rodland KD; Smith RD; Qian WJ; Gong CX; Liu T
J Pathol; 2017 Sep; 243(1):78-88. PubMed ID: 28657654
[TBL] [Abstract][Full Text] [Related]
29. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
30. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Hua X; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
Hum Brain Mapp; 2009 Sep; 30(9):2766-88. PubMed ID: 19172649
[TBL] [Abstract][Full Text] [Related]
31. Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment.
Sultana R; Butterfield DA
Neurochem Res; 2007; 32(4-5):655-62. PubMed ID: 17006763
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.
Nelson PT; Abner EL; Scheff SW; Schmitt FA; Kryscio RJ; Jicha GA; Smith CD; Patel E; Markesbery WR
Neurosci Lett; 2009 Feb; 450(3):336-9. PubMed ID: 19010392
[TBL] [Abstract][Full Text] [Related]
33. Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage.
Shen L; Chen C; Yang A; Chen Y; Liu Q; Ni J
J Proteomics; 2015 Jun; 123():101-13. PubMed ID: 25890254
[TBL] [Abstract][Full Text] [Related]
34. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease.
Cenini G; Sultana R; Memo M; Butterfield DA
Free Radic Biol Med; 2008 Jul; 45(1):81-5. PubMed ID: 18439434
[TBL] [Abstract][Full Text] [Related]
35. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology.
Ikonomovic MD; Mufson EJ; Wuu J; Cochran EJ; Bennett DA; DeKosky ST
J Alzheimers Dis; 2003 Feb; 5(1):39-48. PubMed ID: 12590165
[TBL] [Abstract][Full Text] [Related]
36. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.
Bokde AL; Lopez-Bayo P; Meindl T; Pechler S; Born C; Faltraco F; Teipel SJ; Möller HJ; Hampel H
Brain; 2006 May; 129(Pt 5):1113-24. PubMed ID: 16520329
[TBL] [Abstract][Full Text] [Related]
37. Altered spontaneous activity in Alzheimer's disease and mild cognitive impairment revealed by Regional Homogeneity.
Zhang Z; Liu Y; Jiang T; Zhou B; An N; Dai H; Wang P; Niu Y; Wang L; Zhang X
Neuroimage; 2012 Jan; 59(2):1429-40. PubMed ID: 21907292
[TBL] [Abstract][Full Text] [Related]
38. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
39. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
[TBL] [Abstract][Full Text] [Related]
40. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.
Sultana R; Perluigi M; Butterfield DA
Acta Neuropathol; 2009 Jul; 118(1):131-50. PubMed ID: 19288120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
